SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-11-000742
Filing Date
2011-08-25
Accepted
2011-08-25 07:30:43
Documents
3
Group Members
DOMINIQUE SEMONMERLIN BIOMED PRIVATE EQUITY ADVISORS, LLCMERLIN NEXUS III, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D ss126284_sc13da.htm SC 13D/A 97364
2 AUGUST 25 JOINT LETTER ss126284_ex9906.htm EX-99.6 13000
3 AUGUST 25 PRESS RELEASE ss126284_ex9907.htm EX-99.7 14684
  Complete submission text file 0000947871-11-000742.txt   126486
Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Subject) CIK: 0000902622 (see all company filings)

IRS No.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81358 | Film No.: 111055293
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169
Business Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169 646-227-5270
Merlin BioMed Private Equity Advisors, L.L.C. (Filed by) CIK: 0001429303 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A